Digoxin, Free, Serum
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Evaluating recrudescent (breakthrough) digoxin toxicity in renal-failure patients
Assessing the need for more antidigoxin Fab to be administered
Deciding when to reintroduce digoxin therapy
Monitoring patients with possible digoxin-like immunoreactive factors (DLIFs)
Ultrafiltration Followed by Electrochemiluminescent Immunoassay